Cite
HLA-C and KIR permutations influence chronic obstructive pulmonary disease risk
MLA
Amit Gaggar, et al. “HLA-C and KIR Permutations Influence Chronic Obstructive Pulmonary Disease Risk.” JCI Insight, vol. 6, no. 19, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f92e9bf9fd8a84a59b7fc05709c8ed8f&authtype=sso&custid=ns315887.
APA
Amit Gaggar, Michael H. Cho, Kaiyu Yuan, Thi K. Tran-Nguyen, Joseph M. Pilewski, Yingze Zhang, Jianmin Xue, Frank C. Sciurba, Gerard J. Criner, Steven R. Duncan, Young-il Kim, & Takudzwa Mkorombindo. (2021). HLA-C and KIR permutations influence chronic obstructive pulmonary disease risk. JCI Insight, 6(19).
Chicago
Amit Gaggar, Michael H. Cho, Kaiyu Yuan, Thi K. Tran-Nguyen, Joseph M. Pilewski, Yingze Zhang, Jianmin Xue, et al. 2021. “HLA-C and KIR Permutations Influence Chronic Obstructive Pulmonary Disease Risk.” JCI Insight 6 (19). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f92e9bf9fd8a84a59b7fc05709c8ed8f&authtype=sso&custid=ns315887.